美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Provident Financial Services Inc

16.14

+0.16001.00%

盤後：16.140.00000.00%18:48 EDT

成交量：75.28萬

成交額：1,215.82萬

市值：21.09億

市盈率：13.58

高：16.27

開：15.94

低：15.92

收：15.98

資料載入中...

總覽公司新聞公告

【基石藥業-B(02616.HK)：舒格利單抗GEMSTONE-302長期生存數據再登《柳葉刀•腫瘤學》】智通財經APP

葆元醫藥母公司Nuvation Bio宣佈ROS1抑制劑己二酸他雷替尼獲FDA批准上市

皮下注射“破局”，腫瘤治療迎來“分鐘級”變革

CPHI制药在线

2025年ASCO中國之聲：突破耐藥、填補空白科倫博泰生物蘆康沙妥珠單抗展現EGFR突變非小細胞肺癌治療前景

每日经济新闻

醫藥行業研報：吉利德SG聯合K藥一線治療PD-L1+ TNBC達到PFS主要終點

太平洋证券股份...

Royal Gold將為Solaris的Warintza銅項目提供2億美元資金

上海金属网

吉利德走出水逆？

Ofweek维科网

艾伯維揮起拳頭

【ASCO 2025】亞盛醫藥Bcl-2抑制劑Lisaftoclax獲口頭報告，針對維奈克拉治療失敗患者呈現臨牀潛力

科濟藥業舒瑞基奧侖賽注射液（CT041）的摘要已公佈於ASCO網站

中國多中心研究探索奧雷巴替尼治療慢性期CML的優化劑量

健訊Daily | 鄭州通報“健康證”辦理有關問題；中國醫藥擬3.02億元收購金穗科技100%股權

21世纪经济报道

公積金金融服務盤中異動股價大漲5.67%

康寧傑瑞製藥-B現漲超12% HER2雙抗KN026臨牀研究期中分析達PFS主要終點

港股異動 | 康寧傑瑞製藥-B(09966)漲超12% HER2雙抗KN026臨牀研究期中分析達PFS主要終點

HER2雙抗KN026關鍵性Ⅱ/Ⅲ期臨牀研究期中分析達到PFS主要終點

石藥集團(01093)：KN026關鍵性II╱III期臨牀研究的期中分析達到無進展生存期(PFS)主要終點

康寧傑瑞製藥-B(09966)：KN026關鍵性II/III期臨牀試驗期中分析達到PFS主要終點

信達生物宣佈與奧賽康合作的第三代EGFR TKI 肺癌靶向藥物奧壹新®（利厄替尼片）一線適應症獲批上市

Provident Financial Services Inc 報告截至 3 月 31 日的季度業績 - 盈利摘要

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/PFS/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PFS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PFS\",,,,,undefined,":{"symbol":"PFS","market":"US","secType":"STK","nameCN":"Provident Financial Services Inc","latestPrice":16.14,"timestamp":1750276800000,"preClose":15.98,"halted":0,"volume":752834,"hourTrading":{"tag":"盘后","latestPrice":16.14,"preClose":16.14,"latestTime":"18:48 EDT","volume":97514,"amount":1573829.46,"timestamp":1750286902956},"delay":0,"floatShares":126185309,"shares":130659942,"eps":1.188092,"marketStatus":"六月節休市","change":0.16,"latestTime":"06-18 16:00:00 EDT","open":15.94,"high":16.27,"low":15.92,"amount":12158204.356276,"amplitude":0.021902,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":1.188092,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1750406400000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1042693200000,"exchange":"NYSE","adjPreClose":15.98,"dividendRate":0.05948,"postHourTrading":{"tag":"盘后","latestPrice":16.14,"preClose":16.14,"latestTime":"18:48 EDT","volume":97514,"amount":1573829.46,"timestamp":1750286902956},"volumeRatio":1.4964974639003779,"impliedVol":0.0171,"impliedVolPercentile":0.02},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PFS\",,,,,undefined,":{"symbol":"PFS","floatShares":126185309,"roa":"0.77%","roe":"6.77%","lyrEps":1.053397,"volumeRatio":1.4964974639003779,"shares":130659942,"dividePrice":0.96,"high":16.27,"amplitude":0.021902,"preClose":15.98,"low":15.92,"week52Low":13.07,"pbRate":"0.79","psRate":"3.01","week52High":22.24,"institutionHeld":0.6776,"latestPrice":16.14,"eps":1.188092,"divideRate":0.05948,"volume":752834,"delay":0,"ttmEps":1.188092,"open":15.94,"prevYearClose":18.87,"prevWeekClose":16.43,"prevMonthClose":16.7,"prevQuarterClose":17.17,"fiveDayClose":17.08,"twentyDayClose":17.31,"sixtyDayClose":17.39},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PFS\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2544181398","title":"【基石藥業-B(02616.HK)：舒格利單抗GEMSTONE-302長期生存數據再登《柳葉刀•腫瘤學》】智通財經APP","url":"https://stock-news.laohu8.com/highlight/detail?id=2544181398","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544181398?lang=zh_tw&edition=fundamental","pubTime":"2025-06-19 08:15","pubTimestamp":1750292155,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["OS","BK1161","PFS","02616","BK4097","BK1574","BK4211","III","BK4195","BK4134"],"gpt_icon":0},{"id":"2542595338","title":"葆元醫藥母公司Nuvation Bio宣佈ROS1抑制劑己二酸他雷替尼獲FDA批准上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2542595338","media":"医药时间","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542595338?lang=zh_tw&edition=fundamental","pubTime":"2025-06-12 16:16","pubTimestamp":1749716169,"startTime":"0","endTime":"0","summary":"中国大陆地区商品名为达伯乐，在大中华区由Nuvation Bio的全资子公司葆元医药许可信达生物制药集团负责商业化运营。据估计，约2%的NSCLC患者携带ROS1阳性基因。关于Nuvation Bio和葆元医药Nuvation Bio是一家商业化阶段的全球性抗肿瘤生物制药公司，专注于攻克癌症治疗领域重大难题，进而对患者的生活产生深远的积极影响。葆元医药坐落于浙江省杭州市钱塘区中国医药港，在被Nuvation Bio于2024年4月收购后，成为Nuvation Bio的全资子公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612161826a704d4f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612161826a704d4f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4135","BK4007","BK4211","CNS","PFS","BK4212","ODD","NUVB","BK4183","DDC","IE0009354923.USD","BK4195"],"gpt_icon":0},{"id":"2542319892","title":"皮下注射“破局”，腫瘤治療迎來“分鐘級”變革","url":"https://stock-news.laohu8.com/highlight/detail?id=2542319892","media":"CPHI制药在线","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542319892?lang=zh_tw&edition=fundamental","pubTime":"2025-06-10 18:59","pubTimestamp":1749553190,"startTime":"0","endTime":"0","summary":"6月7日，默沙东皮下注射版PD-1抑制剂帕博利珠单抗正式向中国药监局提交上市申请。这不仅是中国首款申报上市的皮下注射PD-1抗体，更意味着患者未来可能仅需2分钟就能完成抗癌治疗。Halozyme公司认为默沙东皮下注射K药侵犯了其相关专利。除了疗效相当，皮下注射在治疗效率和患者体验方面的优势也十分显著。在患者椅旁停留时间上，皮下注射组较静脉注射组锐减49.7%，从117.2分钟降至59.0分钟。在中国，肿瘤治疗药物的研发竞争也异常激烈。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610192102a4a1e09e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610192102a4a1e09e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B1BXHZ80.USD","MRK","LU0238689110.USD","LU0265550359.USD","LU0208291251.USD","SG9999014559.SGD","LU0320765489.SGD","LU1066051811.HKD","LU2468319806.SGD","IE00BN8TJ469.HKD","LU1291159041.SGD","LU1035773651.USD","LU0203347892.USD","LU0985320562.USD","LU1162221912.USD","LU0106261372.USD","BK4588","LU1057294990.SGD","SGXZ57979304.SGD","LU0265550946.USD","LU1093756325.SGD","IE000M9KFDE8.USD","SG9999014575.USD","LU1983299246.USD","LU0211331839.USD","BK4550","SG9999001440.SGD","LU0203345920.USD","BK4533","ORR","SG9999014567.USD","SG9999002224.SGD","SG9999014542.SGD","LU1066051225.USD","LU0289739699.SGD","BK4516","01877","SG9999015358.SGD","LU2324357040.USD","IE00BJJMRZ35.SGD","LU0965508806.USD","LU1699723380.USD","LU1934455863.HKD","PFS","IE00B2B36J28.USD","LU1934455194.USD","LU2112291526.USD","LU2089984988.USD","BK4195","IE00BLSP4452.SGD","LU0965509283.SGD"],"gpt_icon":0},{"id":"2540039959","title":"2025年ASCO中國之聲：突破耐藥、填補空白 科倫博泰生物蘆康沙妥珠單抗展現EGFR突變非小細胞肺癌治療前景","url":"https://stock-news.laohu8.com/highlight/detail?id=2540039959","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540039959?lang=zh_tw&edition=fundamental","pubTime":"2025-06-04 14:12","pubTimestamp":1749017536,"startTime":"0","endTime":"0","summary":"科伦博泰生物（HK06990）股价再创新高，今日盘中触及363港元/股。消息面上，在近日举行的2025年美国临床肿瘤学会（ASCO）年会上，科伦博泰的TROP2ADC芦康沙妥珠单抗治疗EGFR突变晚期非小细胞肺癌（NSCLC）的多项研究数据重磅公布，其临床价值引发学界广泛关注。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202506043421704414.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202506043421704414.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4097","BK4195","OS","BK4211","PFS","ORR"],"gpt_icon":0},{"id":"2539589248","title":"醫藥行業研報：吉利德SG聯合K藥一線治療PD-L1+ TNBC達到PFS主要終點","url":"https://stock-news.laohu8.com/highlight/detail?id=2539589248","media":"太平洋证券股份...","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539589248?lang=zh_tw&edition=fundamental","pubTime":"2025-05-30 00:00","pubTimestamp":1748534400,"startTime":"0","endTime":"0","summary":"事件：近日，吉利德宣布III 期ASCENT-04 研究达到了PFS 主要终点。核心观点：SG联合K 药一线治疗PD-L1+ TNBC 头对头击败K 药+化疗，PFS 延长具有统计学和临床意义。PD-L1 阳性mTNBC的一线标准治疗为帕博利珠单抗联合化疗，中位PFS 为9.7 个月，mOS为23 个月。此外，SG 对比化疗在一线治疗 PD-L1 阴性TNBC的3 期临床ASCENT-03 也达到了PFS 主要终点。一线PD-L1 阴性TNBC 市场竞争激烈，主要竞品包括Dato、SKB264、BL-B01D1。另一方面，PDL1 阴性TNBC 市场面临激烈竞争。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530144512976ac147&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530144512976ac147&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SGXZ57979304.SGD","LU1116320901.HKD","MRK","LU0320765489.SGD","LU2106854487.HKD","BK4583","LU1929549753.HKD","BK4007","IE00B19Z3581.USD","PD","IE00BLSP4452.SGD","SG","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","LU2461242641.AUD","LU1934455277.USD","IE00BFTCPJ56.SGD","BK4534","GILD","LU0965509010.AUD","IE000M9KFDE8.USD","IE00BSNM7G36.USD","IE00B3T34201.USD","BK4550","LU0106261372.USD","LU1699723380.USD","LU0320765646.SGD","LU0823416689.USD","LU1037948897.HKD","LU1934455863.HKD","IE00B2B36J28.USD","LU0211331839.USD","LU1974910355.USD","BK4566","PFS","IE00BN8TJ469.HKD","LU1037948541.HKD","LU2087621335.USD","LU1989772840.SGD","IE0002141913.USD","SG9999014575.USD","BK4568","LU2361045086.USD","LU1162221912.USD","LU1061106388.HKD","LU2361044949.HKD","LU1066051811.HKD","LU0208291251.USD","LU1941712348.USD"],"gpt_icon":0},{"id":"2539226354","title":"Royal Gold將為Solaris的Warintza銅項目提供2億美元資金","url":"https://stock-news.laohu8.com/highlight/detail?id=2539226354","media":"上海金属网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539226354?lang=zh_tw&edition=fundamental","pubTime":"2025-05-29 14:29","pubTimestamp":1748500164,"startTime":"0","endTime":"0","summary":"SHMET 05月29日讯：据外媒5月21日消息，在多伦多和纽约两地上市的Solaris Resources公司于周三宣布，与贵金属流和权益金公司Royal Gold达成2亿美元融资协议，为其位于厄瓜多尔的旗舰项目Warintza铜矿项目获取非稀释性资金以推进开发。\"Rowlinson补充称，预计黄金流仅占矿山寿命期内黄金产量的极小比例，与权益金结合后，将使Solaris保持项目灵活性。公司预计将于第三季度完成并发布Warintza项目预可行性研究，同时基于超过8.2万米加密钻探成果更新矿产资源估算。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250529210444a6f1e8c0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250529210444a6f1e8c0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0345780281.USD","NSR","BK4585","BK4195","BK4588","FID","RGLD","BK4017","LU0345780521.USD","BK4211","PFS"],"gpt_icon":0},{"id":"2538544575","title":"吉利德走出水逆？","url":"https://stock-news.laohu8.com/highlight/detail?id=2538544575","media":"Ofweek维科网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538544575?lang=zh_tw&edition=fundamental","pubTime":"2025-05-28 13:35","pubTimestamp":1748410505,"startTime":"0","endTime":"0","summary":"2024年，吉利德堪称水逆王者。更紧迫的是，吉利德必须尽快突破乳腺癌的“舒适区”。Trodelvy在肺癌领域的失利阴影尚未消散，而小细胞肺癌、子宫内膜癌等新战场的开拓能否成功，将决定其能否真正走出水逆。4月21日，吉利德宣布，Trodelvy+K药联合一线治疗转移性三阴乳腺癌的ASCENT-04试验获得成功。/ 02 / TNBC攻防战2025年一季度，Trodelvy的销售额出现了下滑，尽管吉利德表示这是库存调整所导致的，但市场竞争的压力不言而喻。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052813350997681163&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052813350997681163&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0211331839.USD","LU1989771016.USD","BK4007","GILD","MRK","LU0320765489.SGD","IE0002270589.USD","IE00BJJMRZ35.SGD","LU1116320901.HKD","IE00BBT3K403.USD","BK4588","BK4534","LU2023250504.SGD","LU0265550359.USD","L","PFS","IE00BN8TJ469.HKD","LU0265550946.USD","LU1989772923.USD","LU1066051811.HKD","LU1839511570.USD","LU0985320562.USD","LU0320765646.SGD","LU0965509101.SGD","LU1941712264.USD","SG9999015341.SGD","LU1066053197.SGD","LU0965508806.USD","LU1674673691.USD","LU1934455863.HKD","LU2106854487.HKD","SG9999002224.SGD","LU0266013472.USD","LU1674673428.USD","LU1974910355.USD","BK4516","IE00B2B36J28.USD","BK4568","BK4139","IE00B7SZLL34.SGD","LU0965509283.SGD","LU1023059063.AUD","LU1116320737.USD","IE00BKVL7J92.USD","LU1093756168.USD","LU0070302665.USD","BK4211","SG9999014575.USD","LU1066051225.USD","LU0889565916.HKD"],"gpt_icon":0},{"id":"2538211551","title":"艾伯維揮起拳頭","url":"https://stock-news.laohu8.com/highlight/detail?id=2538211551","media":"新康界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538211551?lang=zh_tw&edition=fundamental","pubTime":"2025-05-25 10:59","pubTimestamp":1748141979,"startTime":"0","endTime":"0","summary":"艾伯维，作为昔日药王的拥有者，面临专利悬崖压境，举起拳头挥向新战场！表1.艾伯维免疫领域核心产品这一颓势直接拖累艾伯维2024年净利润下跌12.03%。表2.艾伯维肿瘤领域核心产品然而，随着百济神州的泽布替尼、阿斯利康的阿卡替尼等二代BTK抑制剂通过“头对头”试验证明更优疗效与安全性，伊布替尼市场份额被快速瓜分。02频繁动刀为了走出“泥潭”，艾伯维在肿瘤领域多次挥刀，转而瞄准自免与神经科学等赛道。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250525114119a48b5df4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250525114119a48b5df4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0234572021.USD","IE0002270589.USD","SG9999015945.SGD","IE00BDGV0183.EUR","IE00BVYPNV92.GBP","LU0029864427.USD","LU1585245621.USD","IE00B4R5TH58.HKD","LU0122379950.USD","LU2237443895.HKD","PFS","LU2112291526.USD","LU0912757837.SGD","LU1983299246.USD","OS","LU0949170772.SGD","IBD","PROC","SG9999003800.SGD","LU0211327993.USD","LU0820561909.HKD","LU2129689605.HKD","IE0009355771.USD","LU1989772923.USD","CF","LU0861579265.USD","LU1244550494.USD","LU2133065610.SGD","LU1551013425.SGD","IE00B19Z3B42.SGD","BK4566","SG9999015986.USD","LU2237443382.USD","LU1934455863.HKD","LU1244550221.USD","BK4139","BK4097","LU1093756325.SGD","SG9999015952.SGD","LU1162221912.USD","LU0965509101.SGD","IE00BGHQF631.EUR","LU0310800379.SGD","LU2087621335.USD","BK4093","LU0203347892.USD","ABBV","LU1244550577.SGD","IE00B3PB1722.GBP","ORR"],"gpt_icon":0},{"id":"2537906445","title":"【ASCO 2025】亞盛醫藥Bcl-2抑制劑Lisaftoclax獲口頭報告，針對維奈克拉治療失敗患者呈現臨牀潛力","url":"https://stock-news.laohu8.com/highlight/detail?id=2537906445","media":"美通社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537906445?lang=zh_tw&edition=fundamental","pubTime":"2025-05-23 10:51","pubTimestamp":1747968660,"startTime":"0","endTime":"0","summary":"Bcl-2抑制剂lisaftoclax和MDM2-p53抑制剂alrizomadlin均为亚盛医药细胞凋亡管线重点品种。在研新型口服选择性Bcl-2抑制剂lisaftoclax联合阿扎胞苷已在既往临床前和临床研究中显示强劲疗效。数据表明，lisaftoclax联合阿扎胞苷的耐受性良好并已显示初步疗效。仅有3%的患者因中性粒细胞减少下调了lisaftoclax的剂量。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4694966_ZH94966_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["LU2089283258.USD","LU1291159041.SGD","AAPG","LU1116320901.HKD","LU0265550359.USD","LU0211326839.USD","BK4588","LU0496365809.HKD","LU0158827948.USD","LU1571399168.USD","BK1161","BK4211","NCI","IE00BQXX3F31.USD","TRAE","IE00BQXX3C00.GBP","IE00B3T34201.USD","PFS","SD","LU2111349929.HKD","ORR","LU0162691827.USD","LU2023251221.USD","LU0320765489.SGD","MDT","CR","LU2089284900.SGD","BK4533","BK4566","LU0070302665.USD","06855","LU0072461881.USD","LU1989764664.SGD","CDE","BK1574","IE00BFXG1179.USD","LU1983299246.USD","BTC","LU2089984988.USD","BK4017","BK4213","IE00BQXX3D17.EUR","LU1989764748.USD","LU0208291251.USD","LU1116320737.USD","BK4082","BK4585","BK4161","LU2028103732.USD"],"gpt_icon":0},{"id":"2537976421","title":"科濟藥業舒瑞基奧侖賽注射液（CT041）的摘要已公佈於ASCO網站","url":"https://stock-news.laohu8.com/highlight/detail?id=2537976421","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537976421?lang=zh_tw&edition=fundamental","pubTime":"2025-05-23 08:00","pubTimestamp":1747958400,"startTime":"0","endTime":"0","summary":"关于舒瑞基奥仑赛注射液舒瑞基奥仑赛注射液是一款潜在全球同类首创的、靶向Claudin18.2蛋白的自体CAR-T细胞治疗候选产品，用于治疗Claudin18.2阳性实体瘤，主要治疗胃癌/食管胃结合部腺癌及胰腺癌。2020年9月，舒瑞基奥仑赛注射液被美国FDA授予\"孤儿药\"认定用于治疗胃癌/食管胃结合部腺癌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4694213_ZH94213_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK4213","IE00B66KJ199.SGD","BK4195","IE0031619046.USD","LU2065731478.USD","PFS","BK1161","OS","BK1587","BK4022","BK4211","BK4097","BK4230","BK4006","02171","CAR","SOC","BK1574","BK4129","BK1585","CRS","IE00B19Z4B17.USD","IE00B7SZL793.SGD","TPC"],"gpt_icon":0},{"id":"2535538289","title":"中國多中心研究探索奧雷巴替尼治療慢性期CML的優化劑量","url":"https://stock-news.laohu8.com/highlight/detail?id=2535538289","media":"亿欧网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535538289?lang=zh_tw&edition=fundamental","pubTime":"2025-05-16 10:08","pubTimestamp":1747361330,"startTime":"0","endTime":"0","summary":"一项多中心回顾性研究通过倾向性评分匹配比较了奥雷巴替尼40mg隔日一次和30mg QOD起始剂量在慢性髓性白血病患者中的安全性和疗效。研究发现，30mg QOD起始剂量不仅更安全、耐受性更好，而且在疗效上与40mg QOD相当。研究共纳入282例对其他酪氨酸激酶抑制剂耐药或不耐受的成人CML慢性期患者，其中30mg QOD组66例，40mg QOD组216例。经过PSM调整后，两组基线协变量相似。相比之下，40mg QOD组在这些指标上的表现略低。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://ky.jrj.com.cn/2025/05/16100850435864.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK4097","PSM","BK4077","CHR","BK4211","BK4195","PFS","OS"],"gpt_icon":0},{"id":"2535423032","title":"健訊Daily | 鄭州通報“健康證”辦理有關問題；中國醫藥擬3.02億元收購金穗科技100%股權","url":"https://stock-news.laohu8.com/highlight/detail?id=2535423032","media":"21世纪经济报道","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535423032?lang=zh_tw&edition=fundamental","pubTime":"2025-05-14 07:58","pubTimestamp":1747180699,"startTime":"0","endTime":"0","summary":"政策动向国家药监局：全过程深化药品监管改革全方位筑牢药品安全底线5月13日，第36届医药经济信息发布会在广州召开。国家药监局副局长徐景和表示，要全面贯彻落实党的二十届三中全会精神，落实《国务院办公厅关于全面深化药品医疗器械监管改革促进医药产业高质量发展的意见》，全过程深化药品监管改革、全方位筑牢药品安全底线、全链条支持产业高质量发展，为保护和促进公众健康作出更大贡献。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202505143403788212.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202505143403788212.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4017","BK4006","BK4211","BK4195","BK4080","ADC","PFS","BK4097","BK4231","CDE","OS","HCC"],"gpt_icon":0},{"id":"2534271890","title":"公積金金融服務盤中異動 股價大漲5.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534271890","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534271890?lang=zh_tw&edition=fundamental","pubTime":"2025-05-12 21:32","pubTimestamp":1747056733,"startTime":"0","endTime":"0","summary":"北京时间2025年05月12日21时32分，公积金金融服务股票出现波动，股价大幅上涨5.67%。截至发稿，该股报18.08美元/股，成交量2.878万股，换手率0.02%，振幅0.35%。公积金金融服务股票所在的银行行业中，整体涨幅为1.99%。该公司的业务仅限于金融服务行业，包括向客户提供传统银行和其他金融服务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512213213a47b76ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512213213a47b76ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4211","PFS","BK4195"],"gpt_icon":0},{"id":"2532859276","title":"康寧傑瑞製藥-B現漲超12% HER2雙抗KN026臨牀研究期中分析達PFS主要終點","url":"https://stock-news.laohu8.com/highlight/detail?id=2532859276","media":"新浪港股","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532859276?lang=zh_tw&edition=fundamental","pubTime":"2025-05-02 09:50","pubTimestamp":1746150600,"startTime":"0","endTime":"0","summary":"　　康宁杰瑞制药-B盘中涨超12%，截至发稿，股价上涨12.07%，现报7.24港元，成交额1319.95万港元。　　康宁杰瑞生物制药与石药集团共同宣布，HER2双特异性抗体KN026联合化疗二线及以上治疗HER2阳性胃癌的Ⅱ/Ⅲ期临床研究已完成首次期中分析，经独立数据监察委员会评估，达到预先设定的无进展生存期的主要终点，具有统计学显著性和临床意义。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-05-02/doc-inevctpe5151918.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4195","09966","PFS","BK1161","BK4211","BK1574"],"gpt_icon":0},{"id":"2532856051","title":"港股異動 | 康寧傑瑞製藥-B(09966)漲超12% HER2雙抗KN026臨牀研究期中分析達PFS主要終點","url":"https://stock-news.laohu8.com/highlight/detail?id=2532856051","media":"智通财经","labels":["executive","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532856051?lang=zh_tw&edition=fundamental","pubTime":"2025-05-02 09:38","pubTimestamp":1746149889,"startTime":"0","endTime":"0","summary":"消息面上，康宁杰瑞生物制药与石药集团共同宣布，HER2双特异性抗体KN026联合化疗二线及以上治疗HER2阳性胃癌的Ⅱ/Ⅲ期临床研究已完成首次期中分析，经独立数据监察委员会评估，达到预先设定的无进展生存期的主要终点，具有统计学显著性和临床意义。该产品国内权益已出售给石药集团，首付款与里程碑总计10 亿元，双位数销售分成。目前其临床结果十分优秀，与多西他赛联用治疗HER2 阳性BC 的PFS 为 27.7 个月。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1288869.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4211","BK4195","PFS","BK1161","09966","BK1574"],"gpt_icon":0},{"id":"2532701570","title":"HER2雙抗KN026關鍵性Ⅱ/Ⅲ期臨牀研究期中分析達到PFS主要終點","url":"https://stock-news.laohu8.com/highlight/detail?id=2532701570","media":"美通社","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532701570?lang=zh_tw&edition=fundamental","pubTime":"2025-05-01 09:41","pubTimestamp":1746063660,"startTime":"0","endTime":"0","summary":"苏州 2025年5月1日 /美通社/ --康宁杰瑞生物制药与石药集团共同宣布，HER2双特异性抗体KN026联合化疗二线及以上治疗HER2阳性胃癌的Ⅱ/Ⅲ期临床研究已完成首次期中分析，经独立数据监察委员会评估，达到预先设定的无进展生存期的主要终点，具有统计学显著性和临床意义。目前针对二线及以上HER2阳性胃癌/胃食管结合部癌、一线HER2阳性乳腺癌、HER2阳性乳腺癌新辅助等适应症的多项注册临床研究正在进行中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4677725_ZH77725_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK4211","BK1161","BK4195","BK1574","PFS","09966"],"gpt_icon":0},{"id":"2531030234","title":"石藥集團(01093)：KN026關鍵性II╱III期臨牀研究的期中分析達到無進展生存期(PFS)主要終點","url":"https://stock-news.laohu8.com/highlight/detail?id=2531030234","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531030234?lang=zh_tw&edition=fundamental","pubTime":"2025-04-30 21:23","pubTimestamp":1746019419,"startTime":"0","endTime":"0","summary":"智通财经APP讯，石药集团 公布，公司附属公司上海津曼特生物科技有限公司与江苏康宁杰瑞生物制药有限公司合作开发的KN026用于至少接受过一种系统性治疗失败的HER2阳性局部晚期、复发或转移性的胃癌受试者的关键性II╱III期临床研究，经独立数据监察委员会评估，达到预先设定的无进展生存期的主要终点，具有统计学显著性和临床意义。本次计划的期中分析的主要目的是对经IRC评估的PFS进行有效性分析。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1288617.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00BZ08YR35.GBP","IE00B543WZ88.USD","LU1226288170.HKD","BK1515","LU1960683339.HKD","LU1226288253.USD","III","LU1152091168.USD","LU1951186391.HKD","BK4195","IE00BZ08YT58.USD","LU0072913022.USD","BK1191","IE00BZ08YS42.EUR","IE00B5MMRT66.SGD","PFS","LU1226287792.SGD","LU0501845795.SGD","BK4211","LU0880133367.SGD","IE0008369823.USD","BK1521","LU0326950275.SGD","LU1152091754.HKD","LU1993786604.SGD","SG9999004220.SGD","LU0140636845.USD","LU0067412154.USD","LU1226287529.USD","IE0008368742.USD","IE00B031HY20.USD","LU1226287875.USD","LU1008478684.HKD","01093","BK4134","LU1807302812.USD"],"gpt_icon":0},{"id":"2531035965","title":"康寧傑瑞製藥-B(09966)：KN026關鍵性II/III期臨牀試驗期中分析達到PFS主要終點","url":"https://stock-news.laohu8.com/highlight/detail?id=2531035965","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531035965?lang=zh_tw&edition=fundamental","pubTime":"2025-04-30 19:30","pubTimestamp":1746012652,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康宁杰瑞制药-B 发布公告，本公司与石药集团有限公司附属公司上海津曼特生物科技有限公司合作开发的KN026联合化疗二线及以上治疗HER2阳性GC的II/III期临床试验已完成首个期中分析及期中分析结果达到PFS主要终点。KN026-001研究第2部分的首个PFS期中分析结果已由独立数据监察委员会 审查，结果显示达到预先设定的PFS的主要终点，具有统计学显著性和临床意义。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1288556.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","09966","BK1141","PFS","BK1576","BK4211","III","03347","BK4195","BK4134","BK1574","BK1161"],"gpt_icon":0},{"id":"2530119547","title":"信達生物宣佈與奧賽康合作的第三代EGFR TKI 肺癌靶向藥物奧壹新®（利厄替尼片）一線適應症獲批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2530119547","media":"美通社","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530119547?lang=zh_tw&edition=fundamental","pubTime":"2025-04-26 08:00","pubTimestamp":1745625600,"startTime":"0","endTime":"0","summary":"奥壹新是目前唯一获批上市的，以萘胺结构为基础的第三代EGFR-TKI药物。此前，信达生物与奥赛康药业就利厄替尼片在中国已达成独家商业化合作。截至目前，信达生物患者援助项目已惠及20余万普通患者，药物捐赠总价值36亿元人民币。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4673110_ZH73110_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["LU2328871848.SGD","BK4195","BK4135","BK1161","BK1589","BK4570","LU1969619763.USD","BK1583","01801","PFS","PPI","BK4211","LU2488822045.USD","CNS"],"gpt_icon":0},{"id":"2530991735","title":"Provident Financial Services Inc 報告截至 3 月 31 日的季度業績 - 盈利摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2530991735","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530991735?lang=zh_tw&edition=fundamental","pubTime":"2025-04-25 05:40","pubTimestamp":1745530807,"startTime":"0","endTime":"0","summary":"Provident Financial Services Inc 报告截至 3 月 31 日的季度业绩 - 盈利摘要Provident Financial Services Inc PFS.N 公布了截至 3 月 31 日的季度调整后每股收益 49 美分，高于去年同期的每股收益 43 美分。华尔街预期为每股收益 46 美分至 48 美分。Provident Financial Services Inc 公布的本季度每股收益为 49 美分。该公司报告的季度净收入为 6403 万美元。Provident Financial Services Inc 本季度股价下跌了 4.7%，今年迄今为止下跌了 13.2%。华尔街对 Provident Financial Services Inc 的 12 个月目标价中位数为 23.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250424:nL4S3R22F0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4195","BK4211","PFS"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":46,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PFS\",params:#limit:5,,,undefined,":[{"date":"2025-05-16","symbol":"PFS","amount":0.24,"announcedDate":"2025-04-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-05-16","defaultRemindTime":1747402200000,"name":"Provident Financial Services Inc","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-30","payableDate":"2025-05-16","currency":"USD","dateTimestamp":1747368000000,"payDate":"2025-05-30"},{"date":"2025-04-24","symbol":"PFS","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":0.47,"defaultRemindTime":1745524800000,"name":null,"time":"盤後","dateTimestamp":1745467200000,"actualEps":null},{"date":"2025-02-14","symbol":"PFS","amount":0.24,"announcedDate":"2025-01-28","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-02-14","defaultRemindTime":1739543400000,"name":"Provident Financial Services Inc","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-02-28","payableDate":"2025-02-14","currency":"USD","dateTimestamp":1739509200000,"payDate":"2025-02-28"},{"market":"US","date":"2025-01-28","symbol":"PFS","fiscalQuarterEnding":"2024/12","expectedEps":0.5,"name":null,"time":"盤後","type":"earning","dateTimestamp":1738040400000,"reportTimeType":"post","actualEps":0.37},{"date":"2024-11-15","symbol":"PFS","amount":0.24,"announcedDate":"2024-10-29","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-11-15","defaultRemindTime":1731681000000,"name":"Provident Financial Services Inc","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-11-29","payableDate":"2024-11-15","currency":"USD","dateTimestamp":1731646800000,"payDate":"2024-11-29"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PFS\",market:\"US\",,,undefined,":[{"executeDate":"2015-08-12","recordDate":"2015-08-14","paymentDate":"2015-08-28","value":0.16,"currency":"USD"},{"executeDate":"2015-11-10","recordDate":"2015-11-13","paymentDate":"2015-11-27","value":0.17,"currency":"USD"},{"executeDate":"2016-02-10","recordDate":"2016-02-12","paymentDate":"2016-02-26","value":0.17,"currency":"USD"},{"executeDate":"2016-05-11","recordDate":"2016-05-13","paymentDate":"2016-05-31","value":0.18,"currency":"USD"},{"executeDate":"2016-08-11","recordDate":"2016-08-15","paymentDate":"2016-08-31","value":0.18,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PFS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.8333,"hold":0.1667,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.8333,"analysts":6,"updateTime":1734148800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PFS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PFS","date":"2025-06-18","current":14.158349,"percent":0.668269,"low":6.410614,"twenty":8.888967,"median":10.62318,"eighty":16.926427,"high":33.979783,"avg":13.34422,"sd":6.436089,"marketCap":2087945873},"quantilePoints":[{"date":"2020-06-19","current":8.702579,"twenty":13.220184,"median":17.524378,"eighty":19.049774,"marketCap":841313155},{"date":"2020-06-26","current":8.695921,"twenty":13.193521,"median":17.503783,"eighty":19.049774,"marketCap":840669457},{"date":"2020-07-02","current":9.022184,"twenty":13.181803,"median":17.497343,"eighty":19.049774,"marketCap":872210654},{"date":"2020-07-10","current":8.9556,"twenty":13.133798,"median":17.475453,"eighty":19.049774,"marketCap":865773675},{"date":"2020-07-17","current":9.375082,"twenty":13.113766,"median":17.448564,"eighty":19.049774,"marketCap":906326643},{"date":"2020-07-24","current":9.601469,"twenty":13.098537,"median":17.431245,"eighty":19.049774,"marketCap":928212371},{"date":"2020-07-31","current":10.146984,"twenty":13.0648,"median":17.422118,"eighty":19.049774,"marketCap":878647633},{"date":"2020-08-07","current":10.689643,"twenty":13.048711,"median":17.403942,"eighty":19.049774,"marketCap":925637580},{"date":"2020-08-14","current":10.527035,"twenty":13.031177,"median":17.388517,"eighty":19.049774,"marketCap":911556975},{"date":"2020-08-21","current":9.599052,"twenty":13.008395,"median":17.362339,"eighty":19.049774,"marketCap":831201106},{"date":"2020-08-28","current":9.947973,"twenty":12.988694,"median":17.334295,"eighty":19.049774,"marketCap":861414913},{"date":"2020-09-04","current":10.155841,"twenty":12.944965,"median":17.31872,"eighty":19.049774,"marketCap":879414627},{"date":"2020-09-11","current":9.509966,"twenty":12.926046,"median":17.247931,"eighty":19.049774,"marketCap":823486942},{"date":"2020-09-18","current":9.539661,"twenty":12.903594,"median":17.204455,"eighty":19.049774,"marketCap":826058330},{"date":"2020-09-25","current":8.916057,"twenty":12.85637,"median":17.165483,"eighty":19.049774,"marketCap":772059186},{"date":"2020-10-02","current":9.457999,"twenty":12.836682,"median":17.1464,"eighty":19.049774,"marketCap":818987014},{"date":"2020-10-09","current":9.777225,"twenty":12.825762,"median":17.106994,"eighty":19.030829,"marketCap":846629433},{"date":"2020-10-16","current":9.658443,"twenty":12.807943,"median":17.057235,"eighty":18.996004,"marketCap":836343881},{"date":"2020-10-23","current":10.222656,"twenty":12.774984,"median":17.027417,"eighty":18.941136,"marketCap":885200250},{"date":"2020-10-30","current":10.595048,"twenty":12.75677,"median":16.971439,"eighty":18.91343,"marketCap":872343311},{"date":"2020-11-06","current":10.696549,"twenty":12.723452,"median":16.947615,"eighty":18.891695,"marketCap":880700321},{"date":"2020-11-13","current":13.674488,"twenty":12.723452,"median":16.898923,"eighty":18.890505,"marketCap":1125888942},{"date":"2020-11-20","current":14.639195,"twenty":12.723452,"median":16.877422,"eighty":18.890505,"marketCap":1205318094},{"date":"2020-11-27","current":15.191794,"twenty":12.723452,"median":16.856678,"eighty":18.890505,"marketCap":1250816345},{"date":"2020-12-04","current":16.053474,"twenty":12.723452,"median":16.820466,"eighty":18.876273,"marketCap":1321762772},{"date":"2020-12-11","current":16.072206,"twenty":12.723452,"median":16.79439,"eighty":18.876273,"marketCap":1323305085},{"date":"2020-12-18","current":16.222063,"twenty":12.723452,"median":16.774835,"eighty":18.876273,"marketCap":1335643594},{"date":"2020-12-24","current":16.718466,"twenty":12.723452,"median":16.730308,"eighty":18.876273,"marketCap":1376514905},{"date":"2020-12-31","current":16.821493,"twenty":12.723452,"median":16.724895,"eighty":18.876273,"marketCap":1384997630},{"date":"2021-01-08","current":18.095281,"twenty":12.723452,"median":16.724895,"eighty":18.876273,"marketCap":1489874956},{"date":"2021-01-15","current":17.992254,"twenty":12.723452,"median":16.744122,"eighty":18.876273,"marketCap":1481392232},{"date":"2021-01-22","current":18.142111,"twenty":12.723452,"median":16.774835,"eighty":18.876273,"marketCap":1493730740},{"date":"2021-01-29","current":14.720538,"twenty":12.723452,"median":16.78893,"eighty":18.876273,"marketCap":1427170886},{"date":"2021-02-05","current":15.094115,"twenty":12.723452,"median":16.757917,"eighty":18.876273,"marketCap":1463389586},{"date":"2021-02-12","current":15.571023,"twenty":12.723452,"median":16.755695,"eighty":18.876273,"marketCap":1509626224},{"date":"2021-02-19","current":15.626662,"twenty":12.723452,"median":16.724895,"eighty":18.876273,"marketCap":1515020498},{"date":"2021-02-26","current":16.079724,"twenty":12.723452,"median":16.714233,"eighty":18.876273,"marketCap":1558945304},{"date":"2021-03-05","current":17.794179,"twenty":12.721872,"median":16.671636,"eighty":18.877325,"marketCap":1725163471},{"date":"2021-03-12","current":18.789768,"twenty":12.721872,"median":16.671636,"eighty":18.877325,"marketCap":1821686827},{"date":"2021-03-19","current":18.215526,"twenty":12.721872,"median":16.671636,"eighty":18.877325,"marketCap":1766013442},{"date":"2021-03-26","current":18.002063,"twenty":12.723452,"median":16.674486,"eighty":18.876273,"marketCap":1745317972},{"date":"2021-04-01","current":17.749069,"twenty":12.723452,"median":16.674486,"eighty":18.876273,"marketCap":1720790008},{"date":"2021-04-09","current":18.24715,"twenty":12.721872,"median":16.671636,"eighty":18.877325,"marketCap":1769079438},{"date":"2021-04-16","current":18.405271,"twenty":12.721872,"median":16.671636,"eighty":18.877325,"marketCap":1784409415},{"date":"2021-04-23","current":18.674076,"twenty":12.721872,"median":16.671636,"eighty":18.877325,"marketCap":1810470378},{"date":"2021-04-30","current":14.042944,"twenty":12.721872,"median":16.669814,"eighty":18.884491,"marketCap":1833713567},{"date":"2021-05-07","current":15.049841,"twenty":12.721872,"median":16.625436,"eighty":18.884491,"marketCap":1965193242},{"date":"2021-05-14","current":15.169001,"twenty":12.721872,"median":16.591954,"eighty":18.884491,"marketCap":1980752967},{"date":"2021-05-21","current":15.133253,"twenty":12.721872,"median":16.545238,"eighty":18.884491,"marketCap":1976085049},{"date":"2021-05-28","current":15.049841,"twenty":12.721872,"median":16.529666,"eighty":18.884491,"marketCap":1965193242},{"date":"2021-06-04","current":15.043883,"twenty":12.721872,"median":16.506308,"eighty":18.884491,"marketCap":1964415256},{"date":"2021-06-11","current":14.722153,"twenty":12.721872,"median":16.44402,"eighty":18.884491,"marketCap":1922403999},{"date":"2021-06-18","current":13.679507,"twenty":12.721872,"median":16.40509,"eighty":18.884491,"marketCap":1786256407},{"date":"2021-06-25","current":14.227641,"twenty":12.721872,"median":16.3245,"eighty":18.884491,"marketCap":1857831141},{"date":"2021-07-02","current":13.500768,"twenty":12.721872,"median":16.302281,"eighty":18.884491,"marketCap":1762916819},{"date":"2021-07-09","current":13.244575,"twenty":12.721872,"median":16.261288,"eighty":18.884491,"marketCap":1729463411},{"date":"2021-07-16","current":12.976467,"twenty":12.721872,"median":16.250162,"eighty":18.884491,"marketCap":1694454030},{"date":"2021-07-23","current":12.55345,"twenty":12.69964,"median":16.222063,"eighty":18.884491,"marketCap":1639217007},{"date":"2021-07-30","current":10.433885,"twenty":12.684833,"median":16.184117,"eighty":18.884491,"marketCap":1680450278},{"date":"2021-08-06","current":10.849309,"twenty":12.675728,"median":16.148152,"eighty":18.884491,"marketCap":1747357095},{"date":"2021-08-13","current":10.552042,"twenty":12.660863,"median":16.109223,"eighty":18.884491,"marketCap":1699480276},{"date":"2021-08-20","current":10.381313,"twenty":12.614911,"median":16.079724,"eighty":18.884491,"marketCap":1671983067},{"date":"2021-08-27","current":10.571012,"twenty":12.560516,"median":16.051403,"eighty":18.884491,"marketCap":1702535521},{"date":"2021-09-03","current":10.362343,"twenty":12.528973,"median":16.012247,"eighty":18.884491,"marketCap":1668927821},{"date":"2021-09-10","current":10.43348,"twenty":12.478039,"median":15.976834,"eighty":18.884491,"marketCap":1680384992},{"date":"2021-09-17","current":10.542557,"twenty":12.463634,"median":15.915973,"eighty":18.884491,"marketCap":1697952653},{"date":"2021-09-24","current":10.841334,"twenty":12.367008,"median":15.852207,"eighty":18.884491,"marketCap":1746072768},{"date":"2021-10-01","current":11.315583,"twenty":12.317066,"median":15.827979,"eighty":18.884491,"marketCap":1822453904},{"date":"2021-10-08","current":11.718695,"twenty":12.271397,"median":15.788905,"eighty":18.884491,"marketCap":1887377870},{"date":"2021-10-15","current":11.713953,"twenty":12.250326,"median":15.716295,"eighty":18.884491,"marketCap":1886614059},{"date":"2021-10-22","current":11.808802,"twenty":12.188782,"median":15.680935,"eighty":18.884491,"marketCap":1901890286},{"date":"2021-10-29","current":11.169949,"twenty":12.144658,"median":15.649322,"eighty":18.884491,"marketCap":1912127768},{"date":"2021-11-05","current":11.584988,"twenty":12.022084,"median":15.636232,"eighty":18.884491,"marketCap":1983176134},{"date":"2021-11-12","current":11.413559,"twenty":11.87183,"median":15.555472,"eighty":18.877325,"marketCap":1953830070},{"date":"2021-11-19","current":11.06619,"twenty":11.803248,"median":15.475641,"eighty":18.822017,"marketCap":1894365677},{"date":"2021-11-26","current":10.935362,"twenty":11.752841,"median":15.361209,"eighty":18.799671,"marketCap":1871969996},{"date":"2021-12-03","current":10.660174,"twenty":11.700674,"median":15.25837,"eighty":18.766081,"marketCap":1824861840},{"date":"2021-12-10","current":10.64664,"twenty":11.597269,"median":15.189807,"eighty":18.713257,"marketCap":1822545046},{"date":"2021-12-17","current":10.745888,"twenty":11.515514,"median":15.166494,"eighty":18.654746,"marketCap":1839534872},{"date":"2021-12-23","current":10.957919,"twenty":11.442431,"median":15.126556,"eighty":18.639247,"marketCap":1875831320},{"date":"2021-12-31","current":10.92634,"twenty":11.368446,"median":15.085589,"eighty":18.621596,"marketCap":1870425466},{"date":"2022-01-07","current":11.738372,"twenty":11.326022,"median":15.058778,"eighty":18.579091,"marketCap":2009433139},{"date":"2022-01-14","current":11.729349,"twenty":11.326022,"median":15.040904,"eighty":18.531427,"marketCap":2007888610},{"date":"2022-01-21","current":10.863182,"twenty":11.299875,"median":15.028989,"eighty":18.489553,"marketCap":1859613758},{"date":"2022-01-28","current":11.023748,"twenty":11.261979,"median":15.001772,"eighty":18.453467,"marketCap":1851118845},{"date":"2022-02-04","current":11.088134,"twenty":11.181448,"median":14.930112,"eighty":18.423167,"marketCap":1861930553},{"date":"2022-02-11","current":10.92717,"twenty":11.115728,"median":14.912327,"eighty":18.41438,"marketCap":1834901283},{"date":"2022-02-18","current":10.92717,"twenty":11.065654,"median":14.87528,"eighty":18.386528,"marketCap":1834901283},{"date":"2022-02-25","current":10.732094,"twenty":11.023748,"median":14.820597,"eighty":18.371521,"marketCap":1802143926},{"date":"2022-03-04","current":10.629654,"twenty":11.007105,"median":14.772796,"eighty":18.349914,"marketCap":1784942161},{"date":"2022-03-11","current":10.652348,"twenty":10.957288,"median":14.734826,"eighty":18.315942,"marketCap":1788752883},{"date":"2022-03-18","current":10.806664,"twenty":10.92634,"median":14.709739,"eighty":18.308123,"marketCap":1814665792},{"date":"2022-03-25","current":10.720428,"twenty":10.866543,"median":14.669048,"eighty":18.291682,"marketCap":1800185049},{"date":"2022-04-01","current":10.629654,"twenty":10.847714,"median":14.635382,"eighty":18.253335,"marketCap":1784942161},{"date":"2022-04-08","current":10.053238,"twenty":10.819838,"median":14.583758,"eighty":18.229989,"marketCap":1688149823},{"date":"2022-04-14","current":10.071393,"twenty":10.805336,"median":14.512906,"eighty":18.210171,"marketCap":1691198401},{"date":"2022-04-22","current":10.171245,"twenty":10.764,"median":14.497563,"eighty":18.192392,"marketCap":1707965577},{"date":"2022-04-29","current":10.150722,"twenty":10.733654,"median":14.451873,"eighty":18.177577,"marketCap":1657856535},{"date":"2022-05-06","current":10.297502,"twenty":10.713769,"median":14.383195,"eighty":18.14275,"marketCap":1681829155},{"date":"2022-05-13","current":9.954658,"twenty":10.67461,"median":14.304676,"eighty":18.117189,"marketCap":1625834598},{"date":"2022-05-20","current":10.078233,"twenty":10.650249,"median":14.249341,"eighty":18.096905,"marketCap":1646017372},{"date":"2022-05-27","current":10.572534,"twenty":10.629654,"median":14.193648,"eighty":18.064002,"marketCap":1726748469},{"date":"2022-06-03","current":10.412344,"twenty":10.620376,"median":14.117725,"eighty":18.057139,"marketCap":1700585614},{"date":"2022-06-10","current":10.000427,"twenty":10.605236,"median":13.994542,"eighty":18.016495,"marketCap":1633309699},{"date":"2022-06-17","current":9.92262,"twenty":10.570637,"median":13.872371,"eighty":17.998745,"marketCap":1620602026},{"date":"2022-06-24","current":10.165194,"twenty":10.552314,"median":13.685465,"eighty":17.991294,"marketCap":1660220065},{"date":"2022-07-01","current":10.513034,"twenty":10.530137,"median":13.611721,"eighty":17.968495,"marketCap":1717030837},{"date":"2022-07-08","current":10.31623,"twenty":10.524934,"median":13.456373,"eighty":17.95339,"marketCap":1684887900},{"date":"2022-07-15","current":10.288769,"twenty":10.512341,"median":13.392091,"eighty":17.910649,"marketCap":1680402839},{"date":"2022-07-22","current":10.613725,"twenty":10.505887,"median":13.327225,"eighty":17.849237,"marketCap":1733476061},{"date":"2022-07-29","current":11.467199,"twenty":10.505887,"median":13.302306,"eighty":17.813962,"marketCap":1809111112},{"date":"2022-08-05","current":11.377758,"twenty":10.505887,"median":13.239282,"eighty":17.786291,"marketCap":1795000639},{"date":"2022-08-12","current":11.739288,"twenty":10.505887,"median":13.221695,"eighty":17.762714,"marketCap":1852037025},{"date":"2022-08-19","current":11.748717,"twenty":10.505887,"median":13.209959,"eighty":17.748875,"marketCap":1853524605},{"date":"2022-08-26","current":11.296118,"twenty":10.505887,"median":13.188531,"eighty":17.733901,"marketCap":1782120768},{"date":"2022-09-02","current":10.848234,"twenty":10.505887,"median":13.150076,"eighty":17.684237,"marketCap":1711460720},{"date":"2022-09-09","current":10.928381,"twenty":10.505887,"median":13.130958,"eighty":17.66138,"marketCap":1724105150},{"date":"2022-09-16","current":11.036817,"twenty":10.505887,"median":13.113536,"eighty":17.644475,"marketCap":1741212319},{"date":"2022-09-23","current":10.980242,"twenty":10.505887,"median":13.081395,"eighty":17.623016,"marketCap":1732286840},{"date":"2022-09-30","current":9.193418,"twenty":10.478391,"median":13.065324,"eighty":17.59628,"marketCap":1450390441},{"date":"2022-10-07","current":9.075554,"twenty":10.469523,"median":13.052449,"eighty":17.561143,"marketCap":1431795692},{"date":"2022-10-14","current":9.580013,"twenty":10.437974,"median":13.034632,"eighty":17.546569,"marketCap":1511381219},{"date":"2022-10-21","current":9.716736,"twenty":10.425892,"median":13.011756,"eighty":17.514492,"marketCap":1532951128},{"date":"2022-10-28","current":10.271339,"twenty":10.389888,"median":12.992653,"eighty":17.479985,"marketCap":1683636796},{"date":"2022-11-04","current":10.266754,"twenty":10.377223,"median":12.955005,"eighty":17.444428,"marketCap":1682885173},{"date":"2022-11-11","current":10.291061,"twenty":10.357421,"median":12.934931,"eighty":17.408903,"marketCap":1686869566},{"date":"2022-11-18","current":10.064186,"twenty":10.320716,"median":12.924436,"eighty":17.359105,"marketCap":1649681083},{"date":"2022-11-25","current":10.272911,"twenty":10.310098,"median":12.883192,"eighty":17.323674,"marketCap":1683894487},{"date":"2022-12-02","current":10.204848,"twenty":10.293993,"median":12.857307,"eighty":17.216387,"marketCap":1672737942},{"date":"2022-12-09","current":9.973436,"twenty":10.282719,"median":12.842174,"eighty":17.162345,"marketCap":1634805690},{"date":"2022-12-16","current":9.360873,"twenty":10.269156,"median":12.829982,"eighty":17.036971,"marketCap":1534396787},{"date":"2022-12-23","current":9.719335,"twenty":10.253097,"median":12.811402,"eighty":16.964208,"marketCap":1593154590},{"date":"2022-12-30","current":9.69211,"twenty":10.230259,"median":12.79325,"eighty":16.866633,"marketCap":1588691972},{"date":"2023-01-06","current":9.896298,"twenty":10.216454,"median":12.770698,"eighty":16.761899,"marketCap":1622161606},{"date":"2023-01-13","current":10.150398,"twenty":10.193425,"median":12.743914,"eighty":16.690368,"marketCap":1663812707},{"date":"2023-01-20","current":10.213923,"twenty":10.187062,"median":12.725033,"eighty":16.523587,"marketCap":1674225482},{"date":"2023-01-27","current":9.790009,"twenty":10.173843,"median":12.690346,"eighty":16.324736,"marketCap":1719595430},{"date":"2023-02-03","current":10.396723,"twenty":10.16752,"median":12.677807,"eighty":16.256402,"marketCap":1826163591},{"date":"2023-02-10","current":10.238158,"twenty":10.16752,"median":12.667312,"eighty":16.23143,"marketCap":1798311961},{"date":"2023-02-17","current":10.259586,"twenty":10.15802,"median":12.637027,"eighty":16.127135,"marketCap":1802075695},{"date":"2023-02-24","current":10.011024,"twenty":10.149032,"median":12.580612,"eighty":16.062409,"marketCap":1758416384},{"date":"2023-03-03","current":9.946656,"twenty":10.12732,"median":12.54984,"eighty":16.029311,"marketCap":1747110222},{"date":"2023-03-10","current":8.806492,"twenty":10.110262,"median":12.491259,"eighty":15.99002,"marketCap":1546842669},{"date":"2023-03-17","current":8.551231,"twenty":10.087476,"median":12.467781,"eighty":15.924154,"marketCap":1502006690},{"date":"2023-03-24","current":8.308734,"twenty":10.075497,"median":12.378703,"eighty":15.861307,"marketCap":1459412470},{"date":"2023-03-31","current":8.159832,"twenty":10.060803,"median":12.352386,"eighty":15.839714,"marketCap":1433258125},{"date":"2023-04-06","current":7.704617,"twenty":10.04356,"median":12.287536,"eighty":15.796939,"marketCap":1353300555},{"date":"2023-04-14","current":7.832247,"twenty":10.027135,"median":12.261119,"eighty":15.730693,"marketCap":1375718565},{"date":"2023-04-21","current":7.74716,"twenty":10.017452,"median":12.211348,"eighty":15.694,"marketCap":1360773225},{"date":"2023-04-28","current":7.593207,"twenty":9.999766,"median":12.160062,"eighty":15.664957,"marketCap":1307717267},{"date":"2023-05-05","current":6.573548,"twenty":9.989771,"median":12.09154,"eighty":15.642667,"marketCap":1132109520},{"date":"2023-05-12","current":6.495446,"twenty":9.971621,"median":11.987273,"eighty":15.600987,"marketCap":1118658713},{"date":"2023-05-19","current":7.029498,"twenty":9.961387,"median":11.888242,"eighty":15.530275,"marketCap":1210634281},{"date":"2023-05-26","current":7.046909,"twenty":9.952827,"median":11.808802,"eighty":15.39865,"marketCap":1213632756},{"date":"2023-06-02","current":7.116551,"twenty":9.943684,"median":11.780347,"eighty":15.324881,"marketCap":1225626656},{"date":"2023-06-09","current":7.90873,"twenty":9.929925,"median":11.738372,"eighty":15.203096,"marketCap":1362057268},{"date":"2023-06-16","current":7.934846,"twenty":9.905841,"median":11.713953,"eighty":15.174007,"marketCap":1366554981},{"date":"2023-06-23","current":7.221014,"twenty":9.886325,"median":11.649929,"eighty":15.134319,"marketCap":1243617506},{"date":"2023-06-30","current":7.260188,"twenty":9.866996,"median":11.584988,"eighty":15.109317,"marketCap":1250364075},{"date":"2023-07-07","current":6.946798,"twenty":9.848756,"median":11.548897,"eighty":15.068412,"marketCap":1196391525},{"date":"2023-07-14","current":7.499583,"twenty":9.820363,"median":11.505283,"eighty":15.049841,"marketCap":1291593106},{"date":"2023-07-21","current":8.108951,"twenty":9.78572,"median":11.467199,"eighty":15.032889,"marketCap":1396539731},{"date":"2023-07-28","current":8.682159,"twenty":9.742349,"median":11.428126,"eighty":15.003286,"marketCap":1432521431},{"date":"2023-08-04","current":8.409258,"twenty":9.731294,"median":11.387173,"eighty":14.9415,"marketCap":1387493907},{"date":"2023-08-11","current":8.120111,"twenty":9.718285,"median":11.354912,"eighty":14.916422,"marketCap":1339785831},{"date":"2023-08-18","current":7.624539,"twenty":9.704927,"median":11.300777,"eighty":14.879018,"marketCap":1258018387},{"date":"2023-08-25","current":7.506329,"twenty":9.663774,"median":11.282731,"eighty":14.826043,"marketCap":1238514226},{"date":"2023-09-01","current":7.492689,"twenty":9.624389,"median":11.244446,"eighty":14.781733,"marketCap":1236263745},{"date":"2023-09-08","current":7.310828,"twenty":9.599052,"median":11.197237,"eighty":14.751943,"marketCap":1206257344},{"date":"2023-09-15","current":7.388119,"twenty":9.572255,"median":11.168825,"eighty":14.716388,"marketCap":1219010065},{"date":"2023-09-22","current":6.997117,"twenty":9.538302,"median":11.11225,"eighty":14.678775,"marketCap":1154496301},{"date":"2023-09-29","current":6.951652,"twenty":9.501581,"median":11.06619,"eighty":14.644899,"marketCap":1146994701},{"date":"2023-10-06","current":6.951652,"twenty":9.471361,"median":11.046743,"eighty":14.595078,"marketCap":1146994701},{"date":"2023-10-13","current":6.792523,"twenty":9.431033,"median":11.012054,"eighty":14.515019,"marketCap":1120739099},{"date":"2023-10-20","current":6.542463,"twenty":9.372419,"median":10.980475,"eighty":14.499896,"marketCap":1079480297},{"date":"2023-10-27","current":7.170747,"twenty":9.358917,"median":10.957919,"eighty":14.471655,"marketCap":1076479657},{"date":"2023-11-03","current":7.537213,"twenty":9.227549,"median":10.936586,"eighty":14.399708,"marketCap":1131493992},{"date":"2023-11-10","current":7.179977,"twenty":9.151165,"median":10.92634,"eighty":14.31961,"marketCap":1077865333},{"date":"2023-11-17","current":7.734589,"twenty":9.108811,"median":10.883634,"eighty":14.267749,"marketCap":1161124242},{"date":"2023-11-24","current":7.594687,"twenty":9.078197,"median":10.857,"eighty":14.214839,"marketCap":1140121995},{"date":"2023-12-01","current":7.60468,"twenty":8.976162,"median":10.840069,"eighty":14.143037,"marketCap":1141622155},{"date":"2023-12-08","current":8.214253,"twenty":8.928966,"median":10.82028,"eighty":14.03685,"marketCap":1233131947},{"date":"2023-12-15","current":9.103631,"twenty":8.896863,"median":10.805953,"eighty":13.930523,"marketCap":1366646233},{"date":"2023-12-22","current":9.083645,"twenty":8.896863,"median":10.78687,"eighty":13.759594,"marketCap":1363645912},{"date":"2023-12-29","current":9.223547,"twenty":8.892939,"median":10.761277,"eighty":13.668342,"marketCap":1384648159},{"date":"2024-01-05","current":8.743883,"twenty":8.862382,"median":10.745888,"eighty":13.56351,"marketCap":1312640455},{"date":"2024-01-12","current":8.583995,"twenty":8.806492,"median":10.720428,"eighty":13.408162,"marketCap":1288637886},{"date":"2024-01-19","current":8.309187,"twenty":8.772881,"median":10.697142,"eighty":13.342249,"marketCap":1247383472},{"date":"2024-01-26","current":8.828824,"twenty":8.752732,"median":10.656886,"eighty":13.316627,"marketCap":1325391819},{"date":"2024-02-02","current":9.490046,"twenty":8.752732,"median":10.64215,"eighty":13.30073,"marketCap":1218502920},{"date":"2024-02-09","current":8.830529,"twenty":8.752732,"median":10.629654,"eighty":13.236743,"marketCap":1133822213},{"date":"2024-02-16","current":9.326626,"twenty":8.752732,"median":10.620577,"eighty":13.221244,"marketCap":1197520090},{"date":"2024-02-23","current":8.865547,"twenty":8.752732,"median":10.61055,"eighty":13.209959,"marketCap":1138318534},{"date":"2024-03-01","current":8.801346,"twenty":8.74965,"median":10.589265,"eighty":13.19135,"marketCap":1130075279},{"date":"2024-03-08","current":8.986315,"twenty":8.743883,"median":10.567288,"eighty":13.154274,"marketCap":1153824926},{"date":"2024-03-15","current":8.329352,"twenty":8.723902,"median":10.538449,"eighty":13.128485,"marketCap":1069472190},{"date":"2024-03-22","current":8.96157,"twenty":8.698898,"median":10.5269,"eighty":13.112465,"marketCap":1150647615},{"date":"2024-03-28","current":8.466976,"twenty":8.693607,"median":10.517516,"eighty":13.098537,"marketCap":1087142753},{"date":"2024-04-05","current":8.466976,"twenty":8.653336,"median":10.488954,"eighty":13.065324,"marketCap":1087142753},{"date":"2024-04-12","current":7.990046,"twenty":8.61897,"median":10.476162,"eighty":13.052449,"marketCap":1025905922},{"date":"2024-04-19","current":8.671317,"twenty":8.578848,"median":10.466677,"eighty":13.034632,"marketCap":1040072426},{"date":"2024-04-26","current":9.585747,"twenty":8.579877,"median":10.437517,"eighty":13.020302,"marketCap":1149752791},{"date":"2024-05-03","current":9.605463,"twenty":8.579877,"median":10.431596,"eighty":12.999364,"marketCap":1152117669},{"date":"2024-05-10","current":10.091416,"twenty":8.579877,"median":10.40199,"eighty":12.962642,"marketCap":1210404831},{"date":"2024-05-17","current":10.167149,"twenty":8.579877,"median":10.387579,"eighty":12.944965,"marketCap":1219488545},{"date":"2024-05-24","current":9.554974,"twenty":8.579877,"median":10.368229,"eighty":12.926046,"marketCap":1146061860},{"date":"2024-05-31","current":15.595237,"twenty":8.579877,"median":10.368229,"eighty":12.928956,"marketCap":1870555147},{"date":"2024-06-07","current":14.804645,"twenty":8.579877,"median":10.368229,"eighty":12.944965,"marketCap":1775728393},{"date":"2024-06-14","current":14.479745,"twenty":8.579877,"median":10.368229,"eighty":12.974084,"marketCap":1736758494},{"date":"2024-06-21","current":14.609705,"twenty":8.578848,"median":10.365511,"eighty":13.001042,"marketCap":1752346453},{"date":"2024-06-28","current":15.541087,"twenty":8.578848,"median":10.365511,"eighty":13.028149,"marketCap":1864060164},{"date":"2024-07-05","current":15.400297,"twenty":8.578848,"median":10.365511,"eighty":13.034632,"marketCap":1847173207},{"date":"2024-07-12","current":17.403852,"twenty":8.578848,"median":10.365511,"eighty":13.034632,"marketCap":2087487584},{"date":"2024-07-19","current":19.212466,"twenty":8.578848,"median":10.365511,"eighty":13.039572,"marketCap":2304420021},{"date":"2024-07-26","current":32.346496,"twenty":8.578848,"median":10.365511,"eighty":13.039572,"marketCap":2473083727},{"date":"2024-08-02","current":29.436843,"twenty":8.578848,"median":10.365511,"eighty":13.071794,"marketCap":2250623276},{"date":"2024-08-09","current":28.842709,"twenty":8.578848,"median":10.365511,"eighty":13.113823,"marketCap":2205198173},{"date":"2024-08-16","current":30.822445,"twenty":8.578848,"median":10.365511,"eighty":13.134508,"marketCap":2356560887},{"date":"2024-08-23","current":32.631515,"twenty":8.578848,"median":10.365511,"eighty":13.176313,"marketCap":2494875092},{"date":"2024-08-30","current":32.546181,"twenty":8.578848,"median":10.365511,"eighty":13.215944,"marketCap":2488350837},{"date":"2024-09-06","current":31.197913,"twenty":8.578848,"median":10.365511,"eighty":13.228055,"marketCap":2385267609},{"date":"2024-09-13","current":31.300313,"twenty":8.578848,"median":10.365511,"eighty":13.30073,"marketCap":2393096715},{"date":"2024-09-20","current":32.187781,"twenty":8.578848,"median":10.365511,"eighty":13.316627,"marketCap":2460948967},{"date":"2024-09-27","current":31.283246,"twenty":8.578848,"median":10.365511,"eighty":13.405115,"marketCap":2391791864},{"date":"2024-10-04","current":30.429912,"twenty":8.578848,"median":10.365511,"eighty":13.64376,"marketCap":2326549315},{"date":"2024-10-11","current":32.136581,"twenty":8.578848,"median":10.365511,"eighty":13.888037,"marketCap":2457034414},{"date":"2024-10-18","current":33.314182,"twenty":8.578848,"median":10.365511,"eighty":14.144229,"marketCap":2547069132},{"date":"2024-10-25","current":31.88058,"twenty":8.578848,"median":10.365511,"eighty":14.323115,"marketCap":2437461649},{"date":"2024-11-01","current":26.079311,"twenty":8.578848,"median":10.365511,"eighty":14.468915,"marketCap":2459644116},{"date":"2024-11-08","current":29.303632,"twenty":8.578848,"median":10.365511,"eighty":14.501405,"marketCap":2763742765},{"date":"2024-11-15","current":29.608014,"twenty":8.578848,"median":10.365511,"eighty":14.577215,"marketCap":2792450197},{"date":"2024-11-22","current":29.608014,"twenty":8.578848,"median":10.365511,"eighty":14.642195,"marketCap":2792450197},{"date":"2024-11-29","current":29.220619,"twenty":8.578848,"median":10.365511,"eighty":14.720538,"marketCap":2755913466},{"date":"2024-12-06","current":28.72254,"twenty":8.578848,"median":10.365511,"eighty":14.772155,"marketCap":2708937668},{"date":"2024-12-13","current":28.16912,"twenty":8.578848,"median":10.365511,"eighty":14.811522,"marketCap":2656742337},{"date":"2024-12-20","current":26.370502,"twenty":8.578848,"median":10.365511,"eighty":14.879507,"marketCap":2487107512},{"date":"2024-12-27","current":26.107627,"twenty":8.578848,"median":10.365511,"eighty":14.930682,"marketCap":2462314730},{"date":"2025-01-03","current":26.19064,"twenty":8.578848,"median":10.365511,"eighty":15.008136,"marketCap":2470144030},{"date":"2025-01-10","current":24.945443,"twenty":8.578722,"median":10.36461,"eighty":15.045075,"marketCap":2352704535},{"date":"2025-01-17","current":26.730225,"twenty":8.578722,"median":10.36461,"eighty":15.087294,"marketCap":2521034477},{"date":"2025-01-24","current":26.232147,"twenty":8.578722,"median":10.36461,"eighty":15.170193,"marketCap":2474058679},{"date":"2025-01-31","current":20.975271,"twenty":8.578722,"median":10.36461,"eighty":15.27162,"marketCap":2423168232},{"date":"2025-02-07","current":21.686872,"twenty":8.578722,"median":10.36461,"eighty":15.43113,"marketCap":2505375878},{"date":"2025-02-14","current":21.065633,"twenty":8.578722,"median":10.36461,"eighty":15.506431,"marketCap":2433607298},{"date":"2025-02-21","current":20.489576,"twenty":8.578722,"median":10.36461,"eighty":15.601522,"marketCap":2367058251},{"date":"2025-02-28","current":20.614008,"twenty":8.578722,"median":10.36461,"eighty":15.733365,"marketCap":2381433247},{"date":"2025-03-07","current":19.427996,"twenty":8.578596,"median":10.36371,"eighty":15.909803,"marketCap":2244419279},{"date":"2025-03-14","current":19.373214,"twenty":8.58723,"median":10.384564,"eighty":16.110435,"marketCap":2238090520},{"date":"2025-03-21","current":19.113398,"twenty":8.626133,"median":10.390798,"eighty":16.250162,"marketCap":2208075312},{"date":"2025-03-28","current":19.282843,"twenty":8.679674,"median":10.422436,"eighty":16.324736,"marketCap":2227650448},{"date":"2025-04-04","current":17.498022,"twenty":8.697705,"median":10.433885,"eighty":16.538637,"marketCap":2021459018},{"date":"2025-04-11","current":16.594315,"twenty":8.729831,"median":10.450581,"eighty":16.720339,"marketCap":1917058294},{"date":"2025-04-17","current":17.498022,"twenty":8.74788,"median":10.472646,"eighty":16.838352,"marketCap":2021459018},{"date":"2025-04-25","current":14.654875,"twenty":8.784492,"median":10.48224,"eighty":16.926427,"marketCap":2161169063},{"date":"2025-05-02","current":15.142189,"twenty":8.798752,"median":10.513034,"eighty":16.926427,"marketCap":2233033814},{"date":"2025-05-09","current":15.159534,"twenty":8.804878,"median":10.526765,"eighty":16.926427,"marketCap":2235591607},{"date":"2025-05-16","current":15.505075,"twenty":8.82909,"median":10.533858,"eighty":16.926427,"marketCap":2286548985},{"date":"2025-05-23","current":14.787412,"twenty":8.855843,"median":10.556785,"eighty":16.926427,"marketCap":2180714431},{"date":"2025-05-30","current":14.884872,"twenty":8.8606,"median":10.572534,"eighty":16.926427,"marketCap":2195087025},{"date":"2025-06-06","current":14.619071,"twenty":8.875633,"median":10.60779,"eighty":16.926427,"marketCap":2155889043},{"date":"2025-06-13","current":15.000053,"twenty":8.887975,"median":10.619572,"eighty":16.926427,"marketCap":2212072818},{"date":"2025-06-18","current":14.158349,"twenty":8.888967,"median":10.62318,"eighty":16.926427,"marketCap":2087945873}],"updateTime":1750364077711}}}